Jayson Kurfis holds an MS/BS degree in biology and has a publication history that includes peer reviewed articles in cancer and renal disease. Jayson’s cancer work looked at the angiotensin II type 2 receptor and its binding properties while his renal work evaluated the initial stages of acute renal disease and how that impacted the expression of various proteins. His industrial research involved the evaluation of raw materials to ascertain their potential to cause skin irritation. For this work, a 3-dimensional skin model was used. Jayson shifted solely to product management and marketing at MilliporeSigma. The work focused on two product lines; buffers and the biologic preservative Proclin. For buffers, presentations were set up for top tier customers to insure that our products were effective addressing their laboratory needs. The ProClin product line was targeted to the diagnostic market and insured consistent diagnostic results. Jayson has advocated for SE Wisconsin biotech by writing articles for a Chicago-based VC firm, which includes a write-up about the health innovation pitch (HIP) event, investable technology being developed at Blood Center and a description of, Essential Biotechnology LLC, a company that is focused on developing new treatments for ovarian and lung cancer.
Dan Sem has over 20 years of experience with biotech startups and in pharmaceutical development, in both industrial and academic settings. In particular, he has extensive experience in business and intellectual property strategy as it relates to scientific innovation, biotech financing and operations. In this regard, he has worked to assist both students and accomplished researchers in SE Wisconsin in their start-up ventures, via inter-institutional and public-private collaborations. He is passionate about educating students and entrepreneurs about how they can combine business and technical skills to address unmet needs in the world, in a sustainable way. Dan has co-founded two biotechnology companies and one nonprofit focused on mentoring and assisting healthcare entrepreneurs. Dan has a passion is teaching, mentoring and helping others turn their dreams and innovative ideas into sustainable business models and companies that are profitable and have positive social impact (social entrepreneurship). Dan has over 50 peer-reviewed papers and 10 issued patents. He has 25 years of experience studying protein-ligand interactions using various techniques, including NMR, fluorescence spectroscopy, mechanistic enzymology, chemical biology and computational methods (e.g. docking; cheminformatics). Dan’s goals are to combine my business, scientific and legal expertise to develop and help others develop new ways to treat human disease, with emphasis on unmet medical needs (e.g. rare diseases).